Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Breath Biopsy Testing Market Expected To Reach $4.89 Billion By 2030 At 7.3% CAGR
The global market for breath biopsy testing has experienced robust expansion, projecting a rise from $3.43 billion in 2025 to $3.69 billion in 2026, signifying a compound annual growth rate of 7.7%. This historical growth trajectory is underpinned by several key factors, including a heightened demand for non-invasive diagnostic methods, expanded clinical investigations into breath biomarkers, significant technological progress in sensor and spectroscopy applications, the burgeoning growth of diagnostic laboratory services, and an increasing patient inclination towards painless medical examinations.
The market for breath biopsy testing is projected for substantial expansion in the upcoming years, reaching an estimated value of $4.9 billion by 2030 with a compound annual growth rate (CAGR) of 7.3%. This projected growth is propelled by several key factors, including a greater acceptance of breath analysis for standard health screenings, increased financial backing for diagnostic tools powered by artificial intelligence, the broadening scope of personalized medicine, the increasing prevalence of portable diagnostic equipment, and enhanced regulatory endorsement for less invasive diagnostic procedures. During this forecast period, significant market trends are expected to emerge, such as a heightened preference for non-invasive diagnostic methods, a rise in the utilization of volatile organic compound (VOC) detection for identifying diseases, the growing integration of AI in analyzing breath samples, the expansion of handheld breath sampling apparatus, and an intensified emphasis on the early detection of illnesses.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19351&type=smp
#Breath Biopsy Testing Market Growth Factors: Which Forces Are Supporting Market Expansion?
An increasing incidence of respiratory ailments is anticipated to fuel the expansion of the breath biopsy testing sector. These respiratory conditions affect the lungs and breathing passages, impeding effective respiration. Factors contributing to the heightened occurrence of such diseases include escalating environmental pollution, elevated smoking rates, and the growing presence of chronic illnesses like asthma and COPD. Breath biopsy tests are instrumental in diagnosing respiratory diseases by presenting a less invasive, swift, and potentially superior approach to identifying disease-related biomarkers, thereby enhancing early detection and therapeutic strategies. For illustration, data from May 2025 by the Centers for Disease Control and Prevention (CDC) indicate that COPD was the fifth leading cause of mortality in the United States in 2023, with 141,733 fatalities, and the age-adjusted prevalence of diagnosed COPD among adults stood at 3.8% during that same year. Consequently, the escalating rate of respiratory illnesses is poised to be a significant driver for the breath biopsy testing market.
Breath Biopsy Testing Market Segmentation Trends And Revenue Drivers
The breath biopsy testing market covered in this report is segmented –
1) By Type: Volatile Organic Compound Analyzers, Breath Biopsy Kits, Breath Sampler, Other Types
2) By Technology: Fuel Cell Technology, Semiconductor Sensor, Infrared (IR) Spectroscopy, Other Technologies
3) By Application: Hospitals, Clinics, Diagnostics Laboratories, Other Applications
Subsegments:
1) By Volatile Organic Compound (VOC) Analyzers: Gas Chromatography-Mass Spectrometry (GC-MS) Analyzers, Photoionization Detectors (PID), Electronic Nose Devices
2) By Breath Biopsy Kits: Sample Collection Kits, Analysis Kits For Specific Biomarkers, Packaging And Transport Kits
3) By Breath Sampler: Breath Collection Bags, Breath Sampling Tubes, Portable Breath Sampling Devices
4) By Other Types: Breath Testing Devices For Specific Conditions, Software For Data Analysis, Calibration Devices For Breath Analyzers
Breath Biopsy Testing Market Industry Trends: What Changes Are Reshaping Demand?
In the competitive landscape of the breath biopsy testing sector, leading firms are concentrating on pioneering breath analysis devices aimed at diagnosing conditions like asthma. These analyzers function by identifying and quantifying particular substances present in exhaled air, thereby aiding in the diagnosis of illnesses or the evaluation of overall well-being. As an illustration, in May of 2023, GenWorks, a healthcare solutions company headquartered in India, introduced the FenomPro breath analyzer. This particular device distinguishes itself through its swift FeNO testing functionality, producing outcomes in a mere 28 seconds. Engineered for simplicity in clinical environments, it delivers precise evaluations essential for the diagnosis, screening, and ongoing management of asthma. The FenomPro further boasts a rechargeable battery for enhanced mobility, incorporates an intuitive interface, and effectively ascertains the necessity for treatment or the prescription of inhalers for patients.
#Breath Biopsy Testing Market Industry Leaders: Which Organizations Are Driving Competition?
Major companies operating in the breath biopsy testing market are Drägerwerk AG & Co. KGaA, Intoximeters Inc., Owlstone Medical Ltd., SKC Inc, Lifeloc Technologies Inc., Alcolizer Pty Ltd., Breathomix, Aerocrine AB, Bedfont Scientific Ltd., AK GlobalTech Corp., Alveo Technologies Inc., Andatech Pty Ltd., BACtrack, Biosensia Ltd., Ionicon, Ketonix AB, Lion Laboratories Limited, Menssana Research Inc., Microplex Inc., Quest Products Inc., Rapid Biosensor Systems Ltd., RoboScientific Ltd., Spirosure
Access The Complete Breath Biopsy Testing Market Report:
https://www.thebusinessresearchcompany.com/report/breath-biopsy-testing-global-market-report
Breath Biopsy Testing Market Largest Region By Revenue And Market Share
North Americawas the largest region in the breath biopsy testing market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the breath biopsy testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model